扶桑薬品工業の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/07/05 | 2,470 | 2,475 | 2,407 | 2,417 | -44 | -1.8% | 9,800 |
| 2024/07/04 | 2,435 | 2,468 | 2,429 | 2,461 | +26 | +1.1% | 3,700 |
| 2024/07/03 | 2,435 | 2,435 | 2,414 | 2,435 | -5 | -0.2% | 5,300 |
| 2024/07/02 | 2,443 | 2,468 | 2,435 | 2,440 | -3 | -0.1% | 12,200 |
| 2024/07/01 | 2,444 | 2,445 | 2,425 | 2,443 | -1 | ±0% | 8,300 |
| 2024/06/28 | 2,449 | 2,449 | 2,416 | 2,444 | -5 | -0.2% | 14,100 |
| 2024/06/27 | 2,420 | 2,449 | 2,378 | 2,449 | +37 | +1.5% | 21,300 |
| 2024/06/26 | 2,399 | 2,420 | 2,378 | 2,412 | +13 | +0.5% | 13,000 |
| 2024/06/25 | 2,410 | 2,420 | 2,378 | 2,399 | -11 | -0.5% | 18,200 |
| 2024/06/24 | 2,358 | 2,410 | 2,358 | 2,410 | +52 | +2.2% | 16,100 |
| 2024/06/21 | 2,307 | 2,358 | 2,307 | 2,358 | +48 | +2.1% | 15,000 |
| 2024/06/20 | 2,358 | 2,358 | 2,285 | 2,310 | -40 | -1.7% | 18,300 |
| 2024/06/19 | 2,325 | 2,350 | 2,302 | 2,350 | +36 | +1.6% | 15,300 |
| 2024/06/18 | 2,300 | 2,325 | 2,291 | 2,314 | +37 | +1.6% | 12,300 |
| 2024/06/17 | 2,280 | 2,280 | 2,245 | 2,277 | -3 | -0.1% | 7,800 |
| 2024/06/14 | 2,247 | 2,300 | 2,246 | 2,280 | +19 | +0.8% | 16,400 |
| 2024/06/13 | 2,289 | 2,289 | 2,261 | 2,261 | -28 | -1.2% | 10,200 |
| 2024/06/12 | 2,299 | 2,299 | 2,274 | 2,289 | -5 | -0.2% | 6,600 |
| 2024/06/11 | 2,294 | 2,296 | 2,282 | 2,294 | ±0 | ±0% | 3,700 |
| 2024/06/10 | 2,289 | 2,300 | 2,269 | 2,294 | +14 | +0.6% | 8,400 |
| 2024/06/07 | 2,284 | 2,295 | 2,274 | 2,280 | -4 | -0.2% | 1,400 |
| 2024/06/06 | 2,297 | 2,321 | 2,266 | 2,284 | -4 | -0.2% | 12,300 |
| 2024/06/05 | 2,320 | 2,320 | 2,265 | 2,288 | -50 | -2.1% | 14,400 |
| 2024/06/04 | 2,345 | 2,345 | 2,330 | 2,338 | -7 | -0.3% | 5,100 |
| 2024/06/03 | 2,301 | 2,345 | 2,301 | 2,345 | +46 | +2% | 8,400 |
| 2024/05/31 | 2,254 | 2,299 | 2,254 | 2,299 | +45 | +2% | 7,700 |
| 2024/05/30 | 2,242 | 2,255 | 2,227 | 2,254 | +12 | +0.5% | 8,400 |
| 2024/05/29 | 2,260 | 2,270 | 2,242 | 2,242 | -18 | -0.8% | 11,100 |
| 2024/05/28 | 2,277 | 2,287 | 2,260 | 2,260 | -18 | -0.8% | 4,800 |
| 2024/05/27 | 2,280 | 2,280 | 2,261 | 2,278 | -2 | -0.1% | 4,900 |
| 2024/05/24 | 2,266 | 2,283 | 2,254 | 2,280 | -5 | -0.2% | 6,300 |
| 2024/05/23 | 2,279 | 2,285 | 2,261 | 2,285 | +24 | +1.1% | 5,000 |
| 2024/05/22 | 2,269 | 2,277 | 2,261 | 2,261 | -2 | -0.1% | 10,300 |
| 2024/05/21 | 2,287 | 2,287 | 2,257 | 2,263 | -24 | -1% | 7,600 |
| 2024/05/20 | 2,273 | 2,300 | 2,273 | 2,287 | +14 | +0.6% | 13,200 |
| 2024/05/17 | 2,234 | 2,273 | 2,223 | 2,273 | +38 | +1.7% | 9,000 |
| 2024/05/16 | 2,287 | 2,287 | 2,226 | 2,235 | -18 | -0.8% | 8,500 |
| 2024/05/15 | 2,261 | 2,263 | 2,240 | 2,253 | -10 | -0.4% | 4,900 |
| 2024/05/14 | 2,293 | 2,293 | 2,241 | 2,263 | -21 | -0.9% | 9,800 |
| 2024/05/13 | 2,271 | 2,286 | 2,245 | 2,284 | +39 | +1.7% | 20,700 |
| 2024/05/10 | 2,236 | 2,335 | 2,163 | 2,245 | +32 | +1.4% | 51,600 |
| 2024/05/09 | 2,204 | 2,222 | 2,200 | 2,213 | +7 | +0.3% | 5,000 |
| 2024/05/08 | 2,214 | 2,245 | 2,200 | 2,206 | -15 | -0.7% | 4,300 |
| 2024/05/07 | 2,247 | 2,247 | 2,207 | 2,221 | +8 | +0.4% | 3,900 |
| 2024/05/02 | 2,244 | 2,244 | 2,210 | 2,213 | -34 | -1.5% | 5,400 |
| 2024/05/01 | 2,225 | 2,254 | 2,225 | 2,247 | +11 | +0.5% | 8,000 |
| 2024/04/30 | 2,229 | 2,239 | 2,213 | 2,236 | +25 | +1.1% | 10,100 |
| 2024/04/26 | 2,233 | 2,233 | 2,201 | 2,211 | -3 | -0.1% | 13,000 |
| 2024/04/25 | 2,231 | 2,233 | 2,208 | 2,214 | -17 | -0.8% | 8,400 |
| 2024/04/24 | 2,215 | 2,242 | 2,215 | 2,231 | +20 | +0.9% | 12,700 |
201～
250
件表示中 / 3692件
類似銘柄と比較する
現在ご覧いただいている「扶桑薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 扶桑薬 | 238,800円 | +8.3% | +98.1% | 3.43% | 7.85倍 | 0.54倍 |
|
人工腎臓用透析剤・補液が主軸の製薬中堅、透析剤は国内シェア５割。後発薬や製造受託も展開 |
| ミズホメディ | 150,300円 | +1.2% | -13.9% | 5.66% | 8.86倍 | 1.65倍 |
|
体外検査薬専業、感染症抗体、遺伝子検査機器、試薬開発。新型コロナで急成長、妊娠検査薬も |
| アンジェス | 7,800円 | +110.0% | - | 0.00% | - | 12.68倍 |
|
大阪大医学部、森下竜一教授創業の創薬ベンチャー。遺伝子治療薬を核に核酸医薬など開発多彩 |
| ＣＡＮＢＡＳ | 103,600円 | - | - | 0.00% | - | 6.63倍 |
|
抗がん剤開発に特化した創薬ベンチャー。主力の膵臓がん治療薬候補は自社開発。導出も模索 |
| ステムリム | 31,700円 | - | - | 0.00% | - | 2.92倍 |
|
大阪大学発バイオベンチャー。損傷細胞の活性化物質を動員、再生を促す「再生誘導医薬」を開発 |
市場注目の銘柄
チャート関連のコラム
